GGrantIndex
Sort

78,016 grants matching breast cancer

Regulatory Validation of Standardized Clinical Immunohistochemistry Controls

$477,976
Steven A Bogen · Boston Cell Standards Inc · R44 · FY2016 · CA

Prevention of ER-negative Breast Cancer: Identification*

$477,939
Powel H Brown · Baylor College Of Medicine · R01 · FY2006 · CA

Convergent AI for Precise Breast Cancer Risk Assessment

$477,929
Stephen Tc Wong · Methodist Hospital Research Institute · R01 · FY2024 · CA

Translational control of the fibroblast phenotype in IPF

$477,894
Peter B Bitterman · University Of Minnesota · P01 · FY2012 · HL

Translational control of the fibroblast phenotype in IPF

$477,893
Peter B Bitterman · University Of Minnesota · P01 · FY2011 · HL

Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer

$477,871
Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA

SIGNALING PATHWAYS INTERACTIONS AND MAMMARY TUMOR

$477,825
Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · CA

Repurposing Glucosylceramide Synthase to Promote Mitochondrial Lethality and Potentiate an Anti-Tumor Immune Response in Triple-Negative Breast Cancer

$477,817
Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA

Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer

$477,800
Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2023 · CA

Bioinformatics

$477,782
Charles M Perou · Univ Of North Carolina Chapel Hill · P30 · FY2020 · CA

MICROBIOME-DERIVED TRNA Q MODIFICATIONS MEDIATE BREAST CANCER BIOLOGY

$477,763
University Of Illinois · · FY2017 · Department of the Army

Environmental exposure: Susceptibility alleles in a DNA damage response pathway

$477,758
Peter J Stambrook · University Of Cincinnati · R01 · FY2009 · ES

Automated Volumetric Molecular Ultrasound for Breast Cancer Imaging

$477,755
Jeremy Dahl · Stanford University · R01 · FY2017 · CA

Risk Assessment in Community Practice: Developing Better Models

$477,743
Karla M Kerlikowske · Kaiser Foundation Health Plan Of Washington · P01 · FY2015 · CA

Telomere maintenance and replication fork progression in yeast and human cells

$477,729
Virginia A. Zakian · Princeton University · R35 · FY2016 · GM

Exploiting The Heterogeneous Composition Of Tumor Tissue And The Altered Metabolism Of Tumor Cells For Cancer Therapy Design

$477,713
Aniruddha Datta · Texas A&M Engineering Experiment Station · · FY2014 · ENG

Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer

$477,698
Marcus E Peter · Northwestern University At Chicago · R01 · FY2025 · CA

Patient Oriented Outcomes of Prophylactic Mastectomy

$477,675
Kaiser Foundation Research Institute · R01 · FY2002 · CA

Identifying Diagnostic Markers for Cervical Cancer, Breast Cancer, and Prostate

$477,668
Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer

$477,660
George Sgouros · Johns Hopkins University · R01 · FY2015 · CA

Measuring and Modulating DNA Damage Surveillance Pathways

$477,636
Eric T. Kool · Stanford University · R01 · FY2021 · CA

Enhancing neoadjuvant chemotherpay responses with targeted T cells

$477,633
Gerold Bepler · Wayne State University · R01 · FY2015 · CA

Multimode laser optoacoustic tomography system for breast cancer care

$477,627
Alexander A Oraevsky · Tomowave Laboratories, Inc. · R01 · FY2014 · CA

African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus)

$477,599
Valerie McCormack · International Agency For Res On Cancer · R01 · FY2020 · CA

Determinants of Centromere Identity in Drosophila

$477,583
Gary H. Karpen · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2009 · GM